RakeshKumarBagaiMD

PubMed

• 19 citations
  Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming
  Praveena S. Thiagarajan, Xiaoliang Wu, Wei Zhang, Ivy Shi, Rakesh Bagai, Patrick Leahy, Yan Feng, Marty L Veigl, Daniel J. Lindner, David Danielpour, Lihong Yin, Rafae...> ;Oncotarget. 2016 Nov 11
• ZEPHYR illustrates the perils of testing targeted treatments in unselected non-small-cell lung cancer patients.
  Rakesh Bagai, Nathan A. Pennell> ;Translational Lung Cancer Research. 2013 Feb 1
• 1 citations
  Combined treatment with MET inhibitors and other therapies in lung cancer.
  Rakesh Bagai, Patrick C. Ma> ;Translational Lung Cancer Research. 2012 Sep 27
• 106 citations
  Patient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications among Older Adults with Cancer.
  Gopi K. Prithviraj, Siran M. Koroukian, Seunghee Margevicius, Nathan A. Berger, Rakesh Bagai, Cynthia Owusu> ;Journal of Geriatric Oncology. 2012 Jul 1
• 64 citations
  MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
  Weiwen Fan, Zhe Tang, Lihong Yin, Bei H Morrison, Said Hafez-Khayyata, Pingfu Fu, Honglian Huang, Rakesh Bagai, Shan Jiang, Adam Kresak, Scott Howell, Amit Vasanji, Ch...> ;Cancer Research. 2011 Jul 1
• 17 citations
  ARQ-197, an oral small-molecule inhibitor of c-Met for the treatment of solid tumors.
  Rakesh Bagai, Weiwen Fan, Patrick C. Ma> ;Idrugs. 2010 Jun 1
• 44 citations
  Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway.
  Rakesh Bagai, Anna Valujskikh, David H. Canaday, Erin Bailey, Peter N. Lalli, Clifford V. Harding, Peter S. Heeger> ;Journal of Immunology. 2005 Jun 15
• Join now to see all